GAIN:NASDAQGladstone Investment Corporation - Business Development Company Analysis
Data as of 2026-04-05 - not real-time
$14.38
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Gladstone Investment Corp (GAIN) trades at a trailing PE of 4.55, dramatically below the industry average of 16.57, and its price‑to‑book sits under 1 (0.96), indicating a potentially undervalued equity. The stock offers a robust 6.67% dividend yield with a modest payout ratio of 30%, suggesting the dividend is sustainable despite a debt‑to‑equity ratio near 96%. Technicals are neutral: the 20‑day SMA (14.07) is just above the 50‑day SMA (13.95), the MACD histogram is positive (0.018) and the signal is bullish, while price sits between a support of $13.11 and resistance of $14.54. Volume trends are decreasing and 30‑day volatility is about 23%, which combined with a beta of 0.76 points to moderate market sensitivity.
Given the cheap valuation, attractive yield, and solid ROE (~22%), the near‑term outlook leans toward holding, while the medium‑term case supports a buy on the expectation that the market will re‑price the stock closer to its DCF fair value of $6.38. Long‑term investors should monitor the high leverage and cash‑flow profile, but the BDC’s focus on lower‑middle‑market assets and a typical seven‑year investment horizon provide a stable foundation.
Given the cheap valuation, attractive yield, and solid ROE (~22%), the near‑term outlook leans toward holding, while the medium‑term case supports a buy on the expectation that the market will re‑price the stock closer to its DCF fair value of $6.38. Long‑term investors should monitor the high leverage and cash‑flow profile, but the BDC’s focus on lower‑middle‑market assets and a typical seven‑year investment horizon provide a stable foundation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Dividend yield remains attractive at 6.67%
- Technicals are neutral with price near resistance
- Decreasing volume adds short‑term uncertainty
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount (PE 4.55 vs industry 16.57)
- Sustainable dividend and low payout ratio
- Positive MACD signal and modest beta indicating manageable volatility
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt‑to‑equity ratio (~96%) could constrain flexibility
- Consistent ROE (~22%) and strong dividend support
- BDCs' seven‑year investment horizon aligns with GAIN's strategy
Key Metrics & Analysis
Financial Health
Revenue Growth17.30%
Profit Margin118.55%
P/E Ratio4.6
ROE22.16%
ROA2.93%
Debt/Equity96.04
P/B Ratio1.0
Op. Cash Flow$-5745000
Free Cash Flow$29.8M
Industry P/E16.6
Technical Analysis
TrendNeutral
RSI57.2
Support$13.11
Resistance$14.54
MA 20$14.07
MA 50$13.95
MA 200$13.97
MACDBullish
VolumeDecreasing
Fear & Greed Index78.8
Valuation
Fair Value$6.38
Target Price$14.83
Upside/Downside3.15%
GradeUndervalued
TypeValue
Dividend Yield6.67%
Risk Assessment
Beta0.76
Volatility23.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.